Global probiotics group

Probi

Probi develops, produces, markets and sells probiotics globally to food, health and pharmaceutical companies. Probiotics are living microorganisms that have a beneficial effect on health when taken in a sufficient amount. The company's research focuses primarily on gastrointestinal health, immune systems, nutritional and iron intake and metabolic health. The Group is organized in two business areas - Consumer HealthCare and Functional Food.

Financials

PROBI

SEKm 2017 2018 2019
Sales 612 611 791
Sales growth (%) 38,1 -0,2 29,5
EBITDA 158 154 213
EBITDA margin (%) 25,7 25,3 27
EBIT adj 104 103 159
EBIT adj margin (%) 17 16,9 20,1
Pretax profit 93 99 156
EPS rep 6,37 6,72 10,76
EPS growth (%) -22,7 5,4 60,2
EPS adj 6,37 6,72 10,76
DPS 0 1,5 2
EV/EBITDA (x) 24,7 27,6 19,6
EV/EBIT adj (x) 37,3 41,4 26,3
P/E (x) 53,3 56,8 35,5
P/E adj (x) 53,3 56,8 35,5
EV/sales (x) 6,4 7 5,3
FCF yield (%) 3,1 2,6 2,4
Dividend yield (%) 0 0,4 0,5
Net IB debt/EBITDA 0,1 -0,6 -0,8

Main shareholders

Probi

Main shareholders Share capital % Voting shares % Verified
Symrise AG 50.3 % 50.3 % 31 Dec 2017
Swedbank Robur Fonder 11.4 % 11.4 % 30 Sep 2018
Fjärde AP-fonden 8.6 % 8.6 % 30 Sep 2018
Probi Aktiebolag 2.1 % 2.1 % 30 Sep 2018
Avanza Pension 1.1 % 1.1 % 30 Sep 2018
SEB Fonder 1.0 % 1.0 % 30 Sep 2018
Länsförsäkringar Fonder 0.9 % 0.9 % 30 Sep 2018
Catella Fonder 0.6 % 0.6 % 30 Sep 2018
SEBinvest 0.5 % 0.5 % 30 Jun 2018
XACT Fonder 0.5 % 0.5 % 30 Sep 2018

Insider list

Probi

Name
Bengt Peter Nählstedt
INGRID LINDA MARIE NECKMAR
Bengt Peter Nählstedt
EVA REDHE
EVA REDHE
Jonny Olsson
NIKLAS BJÄRUM
INGRID LINDA MARIE NECKMAR
INGRID LINDA MARIE NECKMAR
Niklas Brandt
Show More